![]() |
市場調查報告書
商品編碼
1844352
手術機器人市場機會、成長動力、產業趨勢分析及2025-2034年預測Surgical Robots Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球手術機器人市場價值為 81 億美元,預計到 2034 年將以 17.2% 的複合年成長率成長至 384 億美元。

這一成長的驅動力源於微創手術需求的不斷成長、慢性病發病率的上升、機器人技術的持續進步以及醫療保健支出的增加。醫院和外科中心正在增加對機器人系統的投入,以提高手術精準度、縮短患者康復時間並最大程度地減少手術併發症。手術機器人融合了機械手臂、先進影像技術和即時資料整合技術,為複雜手術提供了更佳的控制力、靈活性和可視性。人工智慧、觸覺回饋和精細成像工具等技術進步正在進一步提升外科醫生的手術能力,同時減輕疲勞。經濟高效的機器人模型(尤其是佔地面積更小、配置更靈活的機器人模型)的出現,正在擴大大型醫院和小型外科中心的機器人應用範圍。此外,機器人即服務 (RaaS) 和租賃等新型商業模式正在消除高昂的前期資本壁壘,從而促進機器人手術的更廣泛應用。這種轉變正在提升機器人手術在不同地區和醫療機構的普及率,確保市場長期成長勢頭,並在全球範圍內實現手術機器人系統的更廣泛部署。
| 市場範圍 | |
|---|---|
| 起始年份 | 2024 |
| 預測年份 | 2025-2034 |
| 起始值 | 81億美元 |
| 預測值 | 384億美元 |
| 複合年成長率 | 17.2% |
2024年,器械及配件市場佔68%的市佔率。這一主導地位源自於機器人輔助手術中頻繁且重複使用的手術器械及配件。與一次性購買的主流機器人系統不同,這些組件在達到一定使用次數後即可更換,為製造商創造了經常性收入來源。這種對耗材的持續需求確保了持續的銷售成長,並支持了市場的永續性。持續的產品升級和器械設計的創新也鞏固了該市場的強勢地位,因為醫療保健提供者正在尋求最新的工具來提高手術精度和手術效果。
預計到2034年,婦科手術市場將以17%的複合年成長率成長。子宮內膜異位症、子宮肌瘤和生殖系統癌症等婦科疾病病例的增加,增加了對外科手術的需求。機器人輔助手術因其能夠減少術後併發症、縮短恢復時間並提高手術精準度,正成為該領域的首選方法。這些優勢在生育相關手術中尤其重要,因為精準度和生殖功能的保留至關重要。
2024年,美國手術機器人市場規模達45億美元,預計複合年成長率達15.9%。美國完善的醫療基礎設施,加上高技術應用率,使得機器人手術在醫院和門診中心廣泛使用。在美國,肥胖、心血管疾病和各種癌症等生活方式疾病的發生率不斷上升,刺激了對外科手術的需求。醫療服務提供者持續採用機器人平台來提高手術精度、簡化工作流程並滿足日益成長的患者期望,從而確保北美市場穩定成長。
影響手術機器人產業競爭格局的關鍵參與者包括 INTUITIVE、meerecompany、CMR SURGICAL、ACCURAY、Stryker、CASCINATION、Medtronic、Smith & Nephew、ELMED MEDICAL SYSTEMS、THINK SURGICAL、GLOBUSRENDICAL、ZIMMER BIOMET、DistGIalmotion、RENAISHAPEN MEDICAL、ZIMMER BIOMET、DistGI。這些公司正透過持續創新和全球擴張策略推動市場向前發展。手術機器人市場的領先製造商正透過策略創新、地理擴張和靈活的商業模式來加強其市場影響力。重點仍然是透過人工智慧功能、即時分析和改進的人體工學來增強機器人系統,以最佳化手術結果並減少臨床醫生的疲勞。各公司也推出了適用於小型手術室的模組化和緊湊型系統,使其產品更容易被中型和地區醫院使用。
The Global Surgical Robots Market was valued at USD 8.1 billion in 2024 and is estimated to grow at a CAGR of 17.2% to reach USD 38.4 billion by 2034.

The growth is driven by the increasing demand for minimally invasive procedures, a rise in chronic disease incidence, continuous advancements in robotic technology, and greater healthcare spending. Hospitals and surgical centers are increasingly investing in robotic systems to improve surgical precision, reduce patient recovery time, and minimize procedural complications. Surgical robots, which combine robotic arms, advanced imaging, and real-time data integration, offer enhanced control, flexibility, and visibility for complex surgeries. Technological advancements such as artificial intelligence, haptic feedback, and refined imaging tools are further enhancing surgeon capabilities while decreasing fatigue. The emergence of cost-effective robotic models, particularly those with smaller footprints and flexible configurations, is expanding access in both large hospitals and smaller surgical centers. Additionally, new business models like Robotics-as-a-Service (RaaS) and leasing are enabling broader adoption by eliminating high upfront capital barriers. This shift is increasing the availability of robotic surgery across different regions and healthcare settings, ensuring long-term market momentum and broader deployment of surgical robotic systems globally.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $8.1 Billion |
| Forecast Value | $38.4 Billion |
| CAGR | 17.2% |
The instruments and accessories segment held 68% share in 2024. This dominance stems from the frequent and recurring use of surgical instruments and accessories in every robotic-assisted procedure. These components, unlike the main robotic systems that represent one-time purchases, require replacement after a set number of uses, creating a recurring revenue stream for manufacturers. This ongoing demand for consumables ensures consistent sales growth and supports market sustainability. Continuous product upgrades and innovation in instrument design also contribute to the segment's strong position, as healthcare providers seek the latest tools for enhanced precision and procedural outcomes.
The gynecology surgery segment is anticipated to grow at a CAGR of 17% through 2034. Rising cases of gynecologic conditions such as endometriosis, fibroids, and reproductive system cancers are increasing the need for surgical interventions. Robotic-assisted surgeries are becoming the preferred approach in this specialty due to their ability to offer reduced postoperative complications, faster recovery times, and greater surgical accuracy. These benefits are particularly important in fertility-related procedures, where precision and preservation of reproductive function are critical.
U.S. Surgical Robots Market was valued at USD 4.5 billion in 2024 and is expected to grow at a CAGR of 15.9%. The country's well-established healthcare infrastructure, combined with a high rate of technological adoption, has led to widespread integration of robotic surgery across hospitals and ambulatory centers. In the U.S., increasing incidences of lifestyle diseases such as obesity, cardiovascular disorders, and various cancers are fueling demand for surgical interventions. Healthcare providers continue to embrace robotic platforms to improve surgical precision, streamline workflows, and meet rising patient expectations, ensuring steady market growth across North America.
Key players influencing the competitive landscape of the Surgical Robots Industry include INTUITIVE, meerecompany, CMR SURGICAL, ACCURAY, Stryker, CASCINATION, Medtronic, Smith & Nephew, ELMED MEDICAL SYSTEMS, THINK SURGICAL, GLOBUS MEDICAL, ZIMMER BIOMET, Distalmotion, RENISHAW, and ASENSUS SURGICAL. These companies are driving the market forward through continued innovation and global expansion strategies. Leading manufacturers in the surgical robots market are strengthening their market presence through strategic innovation, geographic expansion, and flexible business models. A key focus remains on enhancing robotic systems with AI capabilities, real-time analytics, and improved ergonomics to optimize surgical outcomes and reduce clinician fatigue. Companies are also introducing modular and compact systems suitable for smaller operating rooms, making their products more accessible to medium-sized and regional hospitals.